Key points are not available for this paper at this time.
Sophisticated data-mining tools are now available that permit real-time analysis of spontaneous reports of adverse drug reactions. These authors from the European Medicines Agency write that these developments are good news, but there are a number of unintended but foreseeable consequences.
Eichler et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: